Northern Trust Corp C4 Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 489,820 shares of CCCC stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

489,820

Previous 179,573 172.77%

Holding current value

$1.93 Million

Previous $829,000 236.67%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.43 - $7.38 $1.37 Million - $2.29 Million	310,247 Added 172.77%	489,820 $2.79 Million
Q2 2024 Aug 14, 2024	BUY	$4.05 - $8.1 $287,124 - $574,249	70,895 Added 65.23%	179,573 $829,000
Q1 2024 May 14, 2024	BUY	$5.3 - $11.0 $5 - $11	1 Added 0.0%	108,678 $887,000
Q4 2023 Feb 13, 2024	BUY	$1.18 - $6.03 $20,868 - $106,640	17,685 Added 19.44%	108,677 $614,000
Q3 2023 Nov 13, 2023	SELL	$1.81 - $3.89 $300 - $645	-166 Reduced 0.18%	90,992 $169,000
Q2 2023 Aug 11, 2023	SELL	$2.75 - $3.77 $806,976 - $1.11 Million	-293,446 Reduced 76.3%	91,158 $250,000
Q1 2023 May 15, 2023	SELL	$3.1 - $9.02 $44,726 - $130,140	-14,428 Reduced 3.62%	384,604 $1.21 Million
Q4 2022 Feb 13, 2023	BUY	$5.42 - $10.24 $92,405 - $174,581	17,049 Added 4.46%	399,032 $2.35 Million
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $92,047 - $146,382	11,463 Added 3.09%	381,983 $3.35 Million
Q2 2022 Aug 12, 2022	BUY	$5.06 - $26.46 $107,565 - $562,486	21,258 Added 6.09%	370,520 $2.79 Million
Q1 2022 May 13, 2022	SELL	$19.99 - $33.23 $248,555 - $413,181	-12,434 Reduced 3.44%	349,262 $8.47 Million
Q4 2021 Feb 08, 2022	SELL	$29.39 - $46.86 $66,333 - $105,763	-2,257 Reduced 0.62%	361,696 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $2.18 Million - $3.06 Million	60,574 Added 19.97%	363,953 $16.3 Million
Q2 2021 Aug 13, 2021	BUY	$30.39 - $42.18 $5.6 Million - $7.77 Million	184,303 Added 154.78%	303,379 $11.5 Million
Q1 2021 May 12, 2021	SELL	$31.96 - $46.5 $191,568 - $278,721	-5,994 Reduced 4.79%	119,076 $4.41 Million
Q4 2020 Feb 11, 2021	BUY	$22.8 - $37.05 $2.85 Million - $4.63 Million	125,070 New	125,070 $4.14 Million

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $193M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp C4 Therapeutics, Inc. Transaction History